{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:44:48Z","timestamp":1791186288049,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,5]]},"DOI":"10.7759\/cureus.46516","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:39:06Z","timestamp":1696505946000},"source":"Crossref","is-referenced-by-count":3,"title":["Cardiotrophin-1 in Asymptomatic Hypertensive Patients With Mild Diastolic Dysfunction: Potential Prognostic Value in Early Stages of Hypertensive Heart Disease"],"prefix":"10.7759","author":[{"given":"Ioannis","family":"Vlahodimitris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos","family":"Karangelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Moschaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Moyssakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos C","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina N","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iordanis","family":"Mourouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Papadogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia RS","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS, et al.. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006, 355:260-9. 10.1056\/NEJMoa051530","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy AP","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, et al.. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014, 63:1123-33. 10.1016\/j.jacc.2013.11.053","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui AL","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011, 8:30-41. 10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2004.06.002","article-title":"Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure","volume":"88","author":"Izzo JL Jr","year":"2004","unstructured":"Izzo JL Jr, Gradman AH. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. Med Clin North Am. 2004, 88:1257-71. 10.1016\/j.mcna.2004.06.002","journal-title":"Med Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283569a9c","article-title":"An update on biomarkers of heart failure in hypertensive patients","volume":"30","author":"Gluba A","year":"2012","unstructured":"Gluba A, Bielecka-Dabrowa A, Mikhailidis DP, Wong ND, Franklin SS, Rysz J, Banach M. An update on biomarkers of heart failure in hypertensive patients. J Hypertens. 2012, 30:1681-9. 10.1097\/HJH.0b013e3283569a9c","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray JJ","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, et al.. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012, 33:1787-847. 10.1093\/eurheartj\/ehs104","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.05.014","article-title":"Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch","volume":"68","author":"Pemberton CJ","year":"2005","unstructured":"Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res. 2005, 68:109-17. 10.1016\/j.cardiores.2005.05.014","journal-title":"Cardiovasc Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.07.015","article-title":"Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure","volume":"9","author":"Tsutamoto T","year":"2007","unstructured":"Tsutamoto T, Asai S, Tanaka T, et al.. Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure. Eur J Heart Fail. 2007, 9:1032-7. 10.1016\/j.ejheart.2007.07.015","journal-title":"Eur J Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00261.2004","article-title":"Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue","volume":"288","author":"Zolk O","year":"2005","unstructured":"Zolk O, Engmann S, M\u00fcnzel F, Krajcik R. Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. Am J Physiol Endocrinol Metab. 2005, 288:E1214-21. 10.1152\/ajpendo.00261.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvs234","article-title":"Cardiotrophin-1 induces sarcoplasmic reticulum Ca(2+) leak and arrhythmogenesis in adult rat ventricular myocytes","volume":"96","author":"Ruiz-Hurtado G","year":"2012","unstructured":"Ruiz-Hurtado G, G\u00f3mez-Hurtado N, Fern\u00e1ndez-Velasco M, et al.. Cardiotrophin-1 induces sarcoplasmic reticulum Ca(2+) leak and arrhythmogenesis in adult rat ventricular myocytes. Cardiovasc Res. 2012, 96:81-9. 10.1093\/cvr\/cvs234","journal-title":"Cardiovasc Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000191526.68612.49","article-title":"Cardiotrophin: its importance as a pathogenetic factor and as a measure of left ventricular hypertrophy","volume":"23","author":"Schmidt BM","year":"2005","unstructured":"Schmidt BM, Schmieder RE. Cardiotrophin: its importance as a pathogenetic factor and as a measure of left ventricular hypertrophy. J Hypertens. 2005, 23:2151-3. 10.1097\/01.hjh.0000191526.68612.49","journal-title":"J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-9842(00)00105-7","article-title":"The effect of valvular regurgitation on plasma cardiotrophin-1 in patients with normal left ventricular systolic function","volume":"2","author":"Talwar S","year":"2000","unstructured":"Talwar S, Squire IB, Davies JE, Ng LL. The effect of valvular regurgitation on plasma cardiotrophin-1 in patients with normal left ventricular systolic function. Eur J Heart Fail. 2000, 2:387-91. 10.1016\/s1388-9842(00)00105-7","journal-title":"Eur J Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7258(99)00049-2","article-title":"Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues","volume":"85","author":"Latchman DS","year":"2000","unstructured":"Latchman DS. Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues. Pharmacol Ther. 2000, 85:29-37. 10.1016\/s0163-7258(99)00049-2","journal-title":"Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90771-x","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux RB","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986, 57:450-8. 10.1016\/0002-9149(86)90771-x","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.86.4.595","article-title":"Atrial volume in a normal adult population by two-dimensional echocardiography","volume":"86","author":"Wang Y","year":"1984","unstructured":"Wang Y, Gutman JM, Heilbron D, Wahr D, Schiller NB. Atrial volume in a normal adult population by two-dimensional echocardiography. Chest. 1984, 86:595-601. 10.1378\/chest.86.4.595","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of\u00a0Cardiovascular Imaging","volume":"29","author":"Nagueh SF","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of\u00a0Cardiovascular Imaging. J Am Soc Echocardiogr. 2016, 29:277-314. 10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-9842(00)00074-x","article-title":"Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis","volume":"3","author":"Talwar S","year":"2001","unstructured":"Talwar S, Downie PF, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail. 2001, 3:15-9. 10.1016\/s1388-9842(00)00074-x","journal-title":"Eur J Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000184406.12634.f9","article-title":"Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients","volume":"23","author":"Gonz\u00e1lez A","year":"2005","unstructured":"Gonz\u00e1lez A, L\u00f3pez B, Mart\u00edn-Raymondi D, et al.. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J Hypertens. 2005, 23:2297-304. 10.1097\/01.hjh.0000184406.12634.f9","journal-title":"J Hypertens"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12659\/msm.882197","article-title":"Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure","volume":"18","author":"Celik A","year":"2012","unstructured":"Celik A, Sahin S, Koc F, et al.. Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure. Med Sci Monit. 2012, 18:CR25-31. 10.12659\/msm.882197","journal-title":"Med Sci Monit"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01041.2010","article-title":"Role of myosin light chain kinase in cardiotrophin-1-induced cardiac myofibroblast cell migration","volume":"301","author":"Freed DH","year":"2011","unstructured":"Freed DH, Chilton L, Li Y, et al.. Role of myosin light chain kinase in cardiotrophin-1-induced cardiac myofibroblast cell migration. Am J Physiol Heart Circ Physiol. 2011, 301:H514-22. 10.1152\/ajpheart.01041.2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02654","article-title":"Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure","volume":"63","author":"L\u00f3pez B","year":"2014","unstructured":"L\u00f3pez B, Gonz\u00e1lez A, Querejeta R, Larman M, R\u00e1bago G, D\u00edez J. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure. Hypertension. 2014, 63:483-9. 10.1161\/HYPERTENSIONAHA.113.02654","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp498","article-title":"Tissue Doppler E\/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy","volume":"31","author":"Sharp AS","year":"2010","unstructured":"Sharp AS, Tapp RJ, Thom SA, et al.. Tissue Doppler E\/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J. 2010, 31:747-52. 10.1093\/eurheartj\/ehp498","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000160221.09468.d3","article-title":"Is plasma cardiotrophin-1 a marker of hypertensive heart disease?","volume":"23","author":"L\u00f3pez B","year":"2005","unstructured":"L\u00f3pez B, Gonz\u00e1lez A, Lasarte JJ, et al.. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?. J Hypertens. 2005, 23:625-32. 10.1097\/01.hjh.0000160221.09468.d3","journal-title":"J Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.098111","article-title":"Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension","volume":"50","author":"L\u00f3pez B","year":"2007","unstructured":"L\u00f3pez B, Castellano JM, Gonz\u00e1lez A, Barba J, D\u00edez J. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension. Hypertension. 2007, 50:977-83. 10.1161\/HYPERTENSIONAHA.107.098111","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32831ac981","article-title":"Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications","volume":"27","author":"L\u00f3pez B","year":"2009","unstructured":"L\u00f3pez B, Gonz\u00e1lez A, Querejeta R, Barba J, D\u00edez J. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications. J Hypertens. 2009, 27:418-24. 10.1097\/HJH.0b013e32831ac981","journal-title":"J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835ca903","article-title":"Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients","volume":"31","author":"Ravassa S","year":"2013","unstructured":"Ravassa S, Beloqui O, Varo N, et al.. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients. J Hypertens. 2013, 31:587-94. 10.1097\/HJH.0b013e32835ca903","journal-title":"J Hypertens"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1535","article-title":"Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes","volume":"264","author":"Hishinuma S","year":"1999","unstructured":"Hishinuma S, Funamoto M, Fujio Y, Kunisada K, Yamauchi-Takihara K. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun. 1999, 264:436-40. 10.1006\/bbrc.1999.1535","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr202","article-title":"HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia","volume":"92","author":"Robador PA","year":"2011","unstructured":"Robador PA, San Jos\u00e9 G, Rodr\u00edguez C, et al.. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia. Cardiovasc Res. 2011, 92:247-55. 10.1093\/cvr\/cvr202","journal-title":"Cardiovasc Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32828626e2","article-title":"Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure","volume":"25","author":"Gonz\u00e1lez A","year":"2007","unstructured":"Gonz\u00e1lez A, Ravassa S, Loperena I, et al.. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens. 2007, 25:2148-57. 10.1097\/HJH.0b013e32828626e2","journal-title":"J Hypertens"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/148287-cardiotrophin-1-in-asymptomatic-hypertensive-patients-with-mild-diastolic-dysfunction-potential-prognostic-value-in-early-stages-of-hypertensive-heart-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:10Z","timestamp":1707509290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/148287-cardiotrophin-1-in-asymptomatic-hypertensive-patients-with-mild-diastolic-dysfunction-potential-prognostic-value-in-early-stages-of-hypertensive-heart-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.46516","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}